Elixinol Global Limited announced changes to its Board to prepare the company for its next phase of growth and global expansion. The company announced the appointment of Oliver Horn as non-Executive Board Director, effective April 6, 2020. Until recently Mr. Oliver Horn headed Australia's leading vitamins and supplements business Swisse Wellness as CEO ANZ & North America. The company further announced that Elixinol founder Paul Benhaim will take a more active role and has been appointed as Chairman of the Board. Andrew Duff has resigned from his role as Chairman of the Board and Non-Executive Director Greg Ellery has also resigned from the position of Non-Executive Board Director. Following its recent new brand launch of its essential manufacturing and distribution business in the USA and Europe & UK, these appointments are a natural next step in the company's renewal and reset process and have only been made possible by the very strong foundations the previous board and management have put in place.